Nine rare-variant point mutations that occur in close proximity to regulatory phosphorylation sites and the catalytic site on human CaMKK2 have been detected in large-scale genetic studies14, 15, as well as in several cancer cell lines and tissues derived from cancer patients16, 17, 18, 19, 20. Here, CAMKK2 is linked to cancer.